Free Trial

Axonics (AXNX) News Today

$67.57
+0.25 (+0.37%)
(As of 06/21/2024 ET)
Axonics logo with Medical background
Goldman Sachs Group Inc. Boosts Stock Holdings in Axonics, Inc. (NASDAQ:AXNX)
Goldman Sachs Group Inc. boosted its position in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 6.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 621,570 shares of the company's stock after purchasing an add
Axonics logo with Medical background
Axonics, Inc. (NASDAQ:AXNX) Given Consensus Rating of "Hold" by Analysts
Axonics, Inc. (NASDAQ:AXNX - Get Free Report) has received an average recommendation of "Hold" from the thirteen analysts that are currently covering the company, MarketBeat.com reports. Eight analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the
Axonics logo with Medical background
Osterweis Capital Management Inc. Buys 42,439 Shares of Axonics, Inc. (NASDAQ:AXNX)
Osterweis Capital Management Inc. increased its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 69.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 103,614 shares of the company's stock after buying an additional 42,439 shares during the pe
Axonics logo with Medical background
Harbert Fund Advisors Inc. Acquires New Shares in Axonics, Inc. (NASDAQ:AXNX)
Harbert Fund Advisors Inc. acquired a new stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 12,250 shares of the company's stock, valued at approximately $762,000. Several oth
Axonics logo with Medical background
Bellevue Group AG Sells 419,686 Shares of Axonics, Inc. (NASDAQ:AXNX)
Bellevue Group AG reduced its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 18.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,833,165 shares of the company's stock after selling 419,686 shares
Axonics logo with Medical background
Scout Investments Inc. Makes New Investment in Axonics, Inc. (NASDAQ:AXNX)
Scout Investments Inc. purchased a new position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 94,127 shares of the company's stock, valued at approxima
Axonics logo with Medical background
Sectoral Asset Management Inc. Has $2.04 Million Holdings in Axonics, Inc. (NASDAQ:AXNX)
Sectoral Asset Management Inc. cut its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 81.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 32,800 shares of the company's stock after selling 140,150 shares during the
Axonics logo with Medical background
Axonics, Inc. (NASDAQ:AXNX) Shares Bought by Hsbc Holdings PLC
Hsbc Holdings PLC increased its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 26.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 65,494 shares of the company's stock after acquiring an additional 13,734 shares during the period. Hsbc Hold
Axonics logo with Medical background
Norges Bank Invests $37.65 Million in Axonics, Inc. (NASDAQ:AXNX)
Norges Bank acquired a new position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 604,931 shares of the company's stock, valued at approximately $37,645,000. Norges Bank owned
Axonics logo with Medical background
Artisan Partners Limited Partnership Increases Stake in Axonics, Inc. (NASDAQ:AXNX)
Artisan Partners Limited Partnership lifted its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 91.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,220,889 shares of the company's stock after purchasing an additional 58
Axonics logo with Medical background
Dimensional Fund Advisors LP Purchases 56,418 Shares of Axonics, Inc. (NASDAQ:AXNX)
Dimensional Fund Advisors LP raised its position in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 6.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 922,295 shares of the company's stock after purchasing an additional 56,
Axonics logo with Medical background
BNP Paribas Financial Markets Reduces Position in Axonics, Inc. (NASDAQ:AXNX)
BNP Paribas Financial Markets reduced its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 34.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,957 shares of the company's stock after sell
Axonics logo with Medical background
Axonics, Inc. (NASDAQ:AXNX) Receives Average Recommendation of "Hold" from Brokerages
Axonics, Inc. (NASDAQ:AXNX - Get Free Report) has been assigned a consensus rating of "Hold" from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to
International Assets Investment Management LLC Invests $817,000 in Axonics, Inc. (NASDAQ:AXNX)
International Assets Investment Management LLC acquired a new position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 13,131 shares of the company's stock, valued at approximate
Swiss National Bank Has $6.19 Million Holdings in Axonics, Inc. (NASDAQ:AXNX)
Swiss National Bank lessened its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 10.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 99,400 shares of the company's stock after sell
Axonics, Inc. (NASDAQ:AXNX) Short Interest Update
Axonics, Inc. (NASDAQ:AXNX - Get Free Report) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 3,410,000 shares, a decrease of 15.6% from the April 15th total of 4,040,000 shares. Based on an average daily volume of 826,100 shares, the short-interest ratio is presently 4.1 days.
Russell Investments Group Ltd. Has $5.70 Million Holdings in Axonics, Inc. (NASDAQ:AXNX)
Russell Investments Group Ltd. lifted its position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 1,144,500.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 91,568 shares of the company's stock a
Lisanti Capital Growth LLC Boosts Stock Holdings in Axonics, Inc. (NASDAQ:AXNX)
Lisanti Capital Growth LLC lifted its holdings in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 41.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,950 shares of the company's stock afte
Axonics (NASDAQ:AXNX) Rating Reiterated by Needham & Company LLC
Needham & Company LLC reissued a "hold" rating on shares of Axonics in a report on Monday.
Photo of the front of the Boston Scientific Building. Boston Scientific Defies Medtech Slowdown, Raises Outlook
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook (AXNX)
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.
New York State Common Retirement Fund Buys 34,989 Shares of Axonics, Inc. (NASDAQ:AXNX)
New York State Common Retirement Fund boosted its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 28.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 158,657 shares of the company's stock after purchasi
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
Axonics (NASDAQ:AXNX) Announces Quarterly Earnings Results, Misses Expectations By $0.32 EPS
Axonics (NASDAQ:AXNX - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.38) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.32). Axonics had a negative return on equity of 1.00% and a negative net margin of 1.66%. The business had revenue of $91.41 million during the quarter, compared to analysts' expectations of $89.79 million. During the same quarter in the prior year, the firm earned ($0.19) earnings per share. Axonics's quarterly revenue was up 29.4% on a year-over-year basis.
Axonics Reports First Quarter 2024 Financial Results
Axonics, Inc. (NASDAQ:AXNX) Sees Significant Growth in Short Interest
Axonics, Inc. (NASDAQ:AXNX - Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 4,040,000 shares, a growth of 17.4% from the March 31st total of 3,440,000 shares. Based on an average trading volume of 919,900 shares, the short-interest ratio is presently 4.4 days.
Axonics, Inc. (NASDAQ:AXNX) Stake Raised by Jennison Associates LLC
Jennison Associates LLC boosted its holdings in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 56.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 354,331 shares of the company's stock after acquiring an ad
International Assets Investment Management LLC Acquires Shares of 13,131 Axonics, Inc. (NASDAQ:AXNX)
International Assets Investment Management LLC acquired a new stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 13,131 shares of the company's stock, valued at approxim
Calamos Advisors LLC Takes Position in Axonics, Inc. (NASDAQ:AXNX)
Calamos Advisors LLC acquired a new stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 60,694 shares of the company's stock, valued at approximately $3,7
Short Interest in Axonics, Inc. (NASDAQ:AXNX) Increases By 17.0%
Axonics, Inc. (NASDAQ:AXNX - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 3,440,000 shares, a growth of 17.0% from the March 15th total of 2,940,000 shares. Based on an average daily volume of 1,390,000 shares, the days-to-cover ratio is presently 2.5 days.
Impax Asset Management Group plc Has $15.22 Million Holdings in Axonics, Inc. (NASDAQ:AXNX)
Impax Asset Management Group plc lifted its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 244,525 shares of the company's stock afte
Peregrine Capital Management LLC Trims Holdings in Axonics, Inc. (NASDAQ:AXNX)
Peregrine Capital Management LLC cut its position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 14.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 169,629 shares of the
Axonics (NASDAQ:AXNX) Shares Gap Down to $69.65
Axonics (NASDAQ:AXNX) Shares Gap Down to $69.65
Axonics, Inc. (NASDAQ:AXNX) Given Average Recommendation of "Hold" by Analysts
Shares of Axonics, Inc. (NASDAQ:AXNX - Get Free Report) have earned an average rating of "Hold" from the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and five have assigned a buy recommendat
FY2024 EPS Estimates for Axonics, Inc. (NASDAQ:AXNX) Lifted by Analyst
Axonics, Inc. (NASDAQ:AXNX - Free Report) - Investment analysts at Leerink Partnrs upped their FY2024 earnings per share (EPS) estimates for shares of Axonics in a report released on Thursday, March 28th. Leerink Partnrs analyst M. Kratky now forecasts that the company will post earnings of $0.36
Vanguard Group Inc. Sells 72,029 Shares of Axonics, Inc. (NASDAQ:AXNX)
Vanguard Group Inc. cut its position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 1.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,262,314 shares of the company's stock after selling 72,029 shares during
Oak Ridge Investments LLC Buys 47,252 Shares of Axonics, Inc. (NASDAQ:AXNX)
Oak Ridge Investments LLC boosted its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 91.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 98,723 shares of th
Axonics, Inc. (NASDAQ:AXNX) Shares Sold by Ziegler Capital Management LLC
Ziegler Capital Management LLC lowered its position in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 63.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 61,292 shares of the company's stock after selling 104,848 shares during the period. Z
Short Interest in Axonics, Inc. (NASDAQ:AXNX) Grows By 6.4%
Axonics, Inc. (NASDAQ:AXNX - Get Free Report) saw a significant growth in short interest during the month of February. As of February 29th, there was short interest totalling 2,820,000 shares, a growth of 6.4% from the February 14th total of 2,650,000 shares. Based on an average trading volume of 1,220,000 shares, the days-to-cover ratio is presently 2.3 days.
Northern Trust Corp Sells 45,578 Shares of Axonics, Inc. (NASDAQ:AXNX)
Northern Trust Corp lowered its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 6.9% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 611,149 shares of the company's stock after selling 45,578 shares during the period. Northern Trust Corp ow
RTW Investments LP Trims Stock Holdings in Axonics, Inc. (NASDAQ:AXNX)
RTW Investments LP lowered its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 50.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 442,487 shares of the company's st
Get Axonics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXNX and its competitors with MarketBeat's FREE daily newsletter.

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

AXNX Media Mentions By Week

AXNX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AXNX
News Sentiment

1.15

0.71

Average
Medical
News Sentiment

AXNX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AXNX Articles
This Week

3

3

AXNX Articles
Average Week

Get Axonics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXNX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AXNX) was last updated on 6/23/2024 by MarketBeat.com Staff

From Our Partners